Datasets:

electricsheepafrica
/

africa-amr-surveillance

country string	year int64	quarter int64	hospital_tier string	ward string	pathogen string	specimen_type string	infection_source string	patient_age int64	patient_gender string	comorbidity_count int64	hiv_status int64	diabetes int64	malnutrition int64	prior_antibiotic_exposure int64	days_hospitalised int64	icu_stay int64	surgery_30d int64	catheter_days int64	mechanical_ventilation_days int64	stewardship_policy string	livestock_antibiotic_use string	water_sanitation_index int64	hand_hygiene_compliance int64	isolation_practices string	resistance_profile string	mortality_30d int64	label int64	invasive_care_burden float64	comorbidity_vulnerability float64	stewardship_score float64	infection_control_score float64	antibiotic_exposure_risk float64	resistance_severity float64	mortality_risk_score float64
Uganda	2,023	1	Primary	OPD	Salmonella	CSF	Long-term-care	14	Male	1	0	1	0	0	7	0	0	1	1	Basic	Multiple	6	69	Contact	none	0	0	5.1	4	2	43.5	3	0	3.53
Algeria	2,024	3	Secondary	Paediatric	A. baumannii	Respiratory	Community	37	Female	1	1	0	0	1	55	1	1	18	5	Basic	Sulfonamides	5	30	None	Gentamicin,Metronidazole	0	1	49.5	6	2	20	5	2	21.85
Morocco	2,024	2	Secondary	Maternity	E. coli	Stool	Veterinary-contact	71	Male	1	0	0	0	4	36	0	1	19	8	Moderate	None	6	39	Droplet	Ciprofloxacin,Amoxicillin-clav	0	1	45.8	2	4	28.5	8	2	18.74
Zimbabwe	2,022	4	Secondary	Paediatric	A. baumannii	Stool	Community	11	Female	3	0	0	0	2	22	0	0	2	4	Advanced	Penicillin	5	59	None	Gentamicin,Imipenem,Ceftriaxone	1	1	16.6	6	6	34.5	7	3	13.98
Burkina Faso	2,024	3	Primary	Maternity	S. aureus	Blood	Community	24	Male	4	0	0	0	2	37	0	1	1	0	None	Tetracycline	7	47	Droplet	Imipenem,Gentamicin	0	1	12.1	8	0	33.5	7	2	11.63
Nigeria	2,023	3	Primary	Surgical	A. baumannii	Blood	Long-term-care	36	Male	1	0	0	1	0	9	0	0	1	2	Advanced	Sulfonamides	8	75	Contact	none	0	0	7.7	5	6	48.5	3	0	4.81
Zimbabwe	2,023	3	Tertiary	OPD	K. pneumoniae	Blood	Veterinary-contact	10	Male	0	0	0	0	2	60	0	1	0	7	Moderate	Penicillin	6	41	None	Vancomycin,Imipenem	1	1	32	0	4	26.5	7	2	13.6
Egypt	2,023	1	Secondary	Medical	E. coli	Blood	Hospital	50	Female	0	0	0	0	1	3	1	0	3	1	Basic	None	8	92	Droplet	none	0	0	10.9	0	2	57	2	0	3.27
Uganda	2,023	4	Primary	Emergency	S. aureus	Stool	Community	80	Female	1	0	0	1	0	8	0	0	0	1	Moderate	None	7	86	Droplet	none	0	0	4.4	5	4	53	0	0	3.82
DRC	2,022	3	Primary	OPD	K. pneumoniae	CSF	Community	33	Male	2	0	0	0	3	32	0	0	16	11	Basic	Sulfonamides	2	50	None	Metronidazole	0	1	47.6	4	2	27	9	1	18.28
Morocco	2,022	1	Tertiary	ICU	S. aureus	Stool	Community	85	Male	1	0	0	1	2	36	1	0	19	8	Basic	Penicillin	5	62	Contact	Azithromycin	0	1	50.8	5	2	39	7	1	19.74
Burkina Faso	2,023	3	Primary	Paediatric	K. pneumoniae	Blood	Community	30	Male	0	0	0	1	0	5	0	0	2	1	Basic	Penicillin	8	85	Contact	none	0	0	5.5	3	2	53.5	3	0	3.15
Malawi	2,022	2	Private	Medical	A. baumannii	Urine	Community	32	Male	1	0	0	0	0	10	0	0	3	2	Advanced	Sulfonamides	7	72	Droplet	none	0	0	10	2	6	46	3	0	4
Mali	2,019	1	Private	OPD	E. coli	Blood	Community	2	Male	1	0	0	0	0	1	0	0	0	0	Moderate	Tetracycline	10	77	Airborne	none	0	0	0.3	2	4	51.5	3	0	1.09
Morocco	2,019	3	Primary	Surgical	K. pneumoniae	CSF	Long-term-care	54	Female	5	0	1	1	5	15	0	0	14	14	Moderate	Penicillin	8	52	Droplet	Meropenem	1	1	46.5	15	4	37	13	1	23.45
Kenya	2,020	2	Primary	ICU	P. aeruginosa	Respiratory	Community	66	Female	1	0	0	1	0	8	0	1	0	2	Basic	Sulfonamides	9	90	None	none	0	0	6.4	5	2	54	3	0	4.42
Kenya	2,023	2	Secondary	Paediatric	Salmonella	Stool	Hospital	2	Female	5	0	1	0	5	34	1	0	10	7	None	Tetracycline	6	56	None	Meropenem	0	1	39.2	12	0	34	13	1	19.76
Ethiopia	2,020	3	Primary	Surgical	E. coli	CSF	Hospital	33	Female	2	1	0	0	0	7	0	0	2	2	None	Multiple	7	80	None	none	0	0	8.1	8	0	47	3	0	6.43
Egypt	2,020	4	Private	Surgical	E. coli	Stool	Hospital	2	Female	1	0	0	0	1	4	0	0	1	2	None	Penicillin	8	84	None	none	0	0	6.2	2	0	50	5	0	2.86
Burkina Faso	2,021	1	Secondary	Paediatric	P. aeruginosa	Urine	Community	51	Male	2	0	0	0	1	6	0	0	3	2	Advanced	Penicillin	10	84	Droplet	none	0	0	8.8	4	6	55	5	0	4.64
Ethiopia	2,024	1	Primary	OPD	P. aeruginosa	Urine	Hospital	16	Female	1	0	1	0	1	4	0	0	3	1	Moderate	Penicillin	6	84	Contact	none	0	0	6.2	4	4	51	5	0	3.86
Nigeria	2,019	1	Tertiary	ICU	E. coli	CSF	Community	52	Male	5	1	1	0	5	58	1	1	14	0	Moderate	Multiple	7	59	Droplet	Amoxicillin-clav	0	1	36.4	16	4	39.5	13	1	20.92
South Africa	2,020	4	Private	ICU	K. pneumoniae	Blood	Community	22	Male	3	0	0	0	2	7	1	0	19	5	None	Tetracycline	5	39	Droplet	Ciprofloxacin,Meropenem	0	1	36.1	6	0	27.5	7	2	17.83
Ethiopia	2,024	2	Tertiary	Maternity	Shigella	Respiratory	Community	52	Male	2	0	0	0	1	8	0	1	3	2	Basic	None	6	94	Contact	none	0	0	9.4	4	2	56	2	0	4.82
Ghana	2,024	1	Primary	Paediatric	Salmonella	Urine	Community	45	Male	5	0	0	1	1	48	0	0	4	6	None	Sulfonamides	4	54	Contact	Gentamicin,Imipenem	0	1	30.4	13	0	34	5	2	19.62
Morocco	2,021	4	Primary	Paediatric	A. baumannii	Urine	Community	75	Female	1	0	0	0	0	2	0	0	3	2	Advanced	Penicillin	5	60	Contact	none	0	0	7.6	2	6	38	3	0	3.28
Nigeria	2,020	1	Tertiary	OPD	A. baumannii	Urine	Hospital	24	Female	5	1	1	0	5	57	0	0	21	14	None	None	4	62	None	Azithromycin	0	1	66.1	16	0	35	10	1	29.83
Kenya	2,021	2	Tertiary	Emergency	S. aureus	Respiratory	Community	39	Female	1	0	0	0	1	4	0	0	0	0	Moderate	None	9	77	Droplet	none	0	0	1.2	2	4	50.5	2	0	1.36
Zimbabwe	2,019	1	Primary	Emergency	Salmonella	Urine	Hospital	68	Male	0	0	1	1	0	7	0	1	3	1	Basic	None	9	89	Contact	none	0	0	7.1	5	2	56.5	0	0	4.63
Algeria	2,021	2	Primary	Paediatric	E. coli	Respiratory	Community	50	Female	2	0	0	1	0	7	0	0	2	1	Moderate	Multiple	6	75	None	none	0	0	6.1	7	4	43.5	3	0	5.33
Ghana	2,024	2	Tertiary	Maternity	Enterococcus	Blood	Community	42	Male	2	0	0	0	3	15	0	0	11	6	Basic	Tetracycline	8	47	Contact	Imipenem,Vancomycin	0	1	27.5	4	2	34.5	9	2	14.25
Ethiopia	2,024	3	Secondary	ICU	S. aureus	Blood	Community	80	Male	4	0	0	1	4	58	0	0	21	6	None	Tetracycline	6	42	None	Vancomycin,Ceftriaxone,Ciprofloxacin	0	1	50.4	11	0	27	11	3	26.62
Egypt	2,021	2	Secondary	Medical	A. baumannii	Wound	Long-term-care	2	Male	0	0	0	0	2	43	0	1	4	4	None	Multiple	4	67	None	Imipenem,Ciprofloxacin	0	1	24.9	0	0	37.5	7	2	11.47
Senegal	2,022	3	Primary	Emergency	S. pneumoniae	Respiratory	Community	51	Male	2	0	0	1	2	15	0	0	0	11	Advanced	Sulfonamides	4	29	Contact	Amoxicillin-clav,Vancomycin	1	1	26.5	7	6	21.5	7	2	15.45
Morocco	2,024	3	Primary	Surgical	P. aeruginosa	Blood	Community	65	Female	2	0	0	1	0	10	0	0	2	1	Moderate	Multiple	9	64	Airborne	none	0	0	7	7	4	44	3	0	5.6
Senegal	2,019	4	Primary	Maternity	E. coli	Wound	Veterinary-contact	17	Female	5	0	0	0	1	36	1	1	1	0	Moderate	Multiple	2	35	Droplet	Imipenem,Ciprofloxacin	1	1	16.8	10	4	22.5	5	2	14.04
South Africa	2,023	1	Primary	Maternity	P. aeruginosa	Blood	Community	15	Male	0	1	0	0	1	5	0	0	0	1	Basic	Multiple	10	64	None	none	0	0	3.5	4	2	42	5	0	3.05
Ethiopia	2,021	4	Tertiary	Paediatric	P. aeruginosa	Blood	Community	10	Female	5	0	0	0	1	13	0	1	12	10	Basic	Sulfonamides	7	62	Contact	Vancomycin	0	1	35.9	10	2	41	5	1	17.77
Burkina Faso	2,023	2	Tertiary	Medical	S. pneumoniae	Respiratory	Community	34	Female	5	0	0	0	4	18	0	1	10	0	Moderate	Penicillin	8	28	Contact	Ceftriaxone,Gentamicin,Azithromycin	1	1	15.4	10	4	25	11	3	15.62
Malawi	2,023	4	Secondary	Maternity	K. pneumoniae	Wound	Community	71	Male	1	1	0	0	1	10	0	0	3	2	Moderate	None	6	77	Contact	none	0	0	10	6	4	47.5	2	0	6
Egypt	2,021	2	Primary	OPD	S. pneumoniae	Respiratory	Hospital	67	Male	0	0	0	0	0	3	0	0	1	0	Moderate	Tetracycline	5	62	Droplet	none	0	0	1.9	0	4	39	3	0	0.57
Nigeria	2,022	4	Primary	OPD	K. pneumoniae	Stool	Hospital	47	Male	2	0	0	0	5	50	0	1	13	4	Basic	Penicillin	5	40	None	Amoxicillin-clav,Azithromycin,Ceftriaxone	0	1	36	4	2	25	13	3	18.8
Malawi	2,020	4	Private	Emergency	Salmonella	Blood	Community	67	Female	1	0	0	0	0	4	0	0	2	2	Basic	Multiple	7	92	Contact	none	0	0	7.2	2	2	56	3	0	3.16
Kenya	2,022	4	Secondary	Medical	Shigella	Respiratory	Community	81	Female	4	1	0	1	3	9	0	0	11	6	None	Multiple	3	34	None	Gentamicin,Amoxicillin-clav,Azithromycin	0	1	25.7	15	0	20	9	3	21.21
DRC	2,022	4	Primary	Maternity	P. aeruginosa	Wound	Community	24	Male	0	0	0	0	0	10	0	1	1	0	Advanced	Tetracycline	5	70	Droplet	none	0	0	4	0	6	43	3	0	1.2
Burkina Faso	2,022	3	Secondary	OPD	Salmonella	Blood	Hospital	75	Female	3	0	0	0	1	19	1	0	0	0	None	None	6	60	None	Gentamicin,Ceftriaxone,Imipenem	0	1	10.7	6	0	36	2	3	12.21
Burkina Faso	2,023	1	Tertiary	OPD	E. coli	Respiratory	Community	29	Male	0	0	1	0	4	51	0	0	7	10	None	Sulfonamides	4	68	Contact	Ciprofloxacin,Metronidazole	1	1	42.3	2	0	41	11	2	17.69
DRC	2,020	3	Tertiary	Medical	S. aureus	Respiratory	Community	59	Male	5	0	1	0	4	39	0	0	10	10	Basic	Sulfonamides	4	29	None	Vancomycin	0	1	41.7	12	2	18.5	11	1	20.51
Ghana	2,021	2	Tertiary	OPD	E. coli	Wound	Community	8	Female	2	0	0	1	5	24	1	0	8	2	Basic	Penicillin	2	26	Contact	Gentamicin,Amoxicillin-clav	0	1	24.2	7	2	18	13	2	14.76
Nigeria	2,019	2	Secondary	Emergency	N. gonorrhoeae	Respiratory	Community	27	Male	3	0	0	0	2	9	0	1	15	1	Basic	Tetracycline	8	46	None	Metronidazole,Azithromycin	0	1	19.7	6	2	31	7	2	12.91
Senegal	2,020	3	Secondary	Medical	E. coli	CSF	Long-term-care	82	Male	5	0	0	1	3	35	0	0	0	12	None	Multiple	4	64	Droplet	Imipenem,Ciprofloxacin,Meropenem	1	1	34.5	13	0	39	9	3	22.85
Nigeria	2,023	4	Secondary	Surgical	A. baumannii	Wound	Community	8	Female	2	0	0	0	1	8	0	0	3	2	Basic	Multiple	9	75	Contact	none	0	0	9.4	4	2	49.5	5	0	4.82
Ghana	2,020	2	Secondary	OPD	K. pneumoniae	CSF	Community	24	Male	3	0	0	0	3	3	0	1	10	5	Advanced	Multiple	8	53	Droplet	Vancomycin	1	1	20.9	6	6	37.5	9	1	11.27
Niger	2,019	4	Secondary	Surgical	S. pneumoniae	Blood	Hospital	55	Male	2	1	0	0	0	2	0	0	0	0	Basic	Penicillin	10	95	Contact	none	0	0	0.6	8	2	60.5	3	0	4.18
Malawi	2,024	2	Primary	Paediatric	E. coli	Urine	Community	48	Male	5	0	1	0	4	4	0	1	9	5	None	Tetracycline	8	59	Airborne	Meropenem,Ceftriaxone	0	1	20.2	12	0	40.5	11	2	16.06
Nigeria	2,020	4	Secondary	Paediatric	E. coli	CSF	Community	83	Male	2	0	0	0	1	6	0	0	3	1	Moderate	Penicillin	5	66	Contact	none	0	0	6.8	4	4	41	5	0	4.04
South Africa	2,020	2	Primary	Surgical	A. baumannii	Stool	Community	36	Female	4	0	0	1	2	50	0	1	12	6	Basic	Tetracycline	4	51	Contact	Ciprofloxacin,Ceftriaxone,Vancomycin	0	1	39	11	2	32.5	7	3	23.2
Kenya	2,023	1	Secondary	Medical	N. gonorrhoeae	Blood	Hospital	54	Female	2	0	0	0	1	3	0	0	0	2	Moderate	Sulfonamides	8	65	Contact	none	0	0	4.9	4	4	43.5	5	0	3.47
Mali	2,021	3	Secondary	Maternity	E. coli	Wound	Long-term-care	31	Female	5	0	1	0	5	42	1	0	9	3	Moderate	Sulfonamides	6	70	Droplet	Vancomycin,Metronidazole	1	1	32.6	12	4	44	13	2	19.78
Uganda	2,021	4	Tertiary	Medical	S. aureus	CSF	Hospital	35	Female	3	0	0	1	3	35	1	0	4	5	Basic	None	8	37	None	Amoxicillin-clav,Vancomycin	1	1	29.5	9	2	26.5	6	2	17.35
Burkina Faso	2,021	4	Tertiary	Emergency	S. pneumoniae	Stool	Community	17	Male	2	0	0	0	4	13	0	0	20	5	None	None	7	70	None	Ceftriaxone	0	1	33.9	4	0	42	8	1	14.17
Morocco	2,022	1	Secondary	Maternity	P. aeruginosa	Urine	Community	2	Male	0	0	0	0	1	2	0	0	3	2	Advanced	Multiple	10	87	Contact	none	0	0	7.6	0	6	56.5	5	0	2.28
Morocco	2,023	2	Secondary	ICU	K. pneumoniae	Blood	Community	74	Female	2	0	0	0	1	10	0	0	3	0	Moderate	None	10	64	Airborne	none	0	0	6	4	4	45	2	0	3.8
Cote d'Ivoire	2,022	4	Tertiary	Maternity	E. coli	Respiratory	Hospital	58	Male	2	0	0	0	5	43	1	0	19	6	Moderate	None	6	56	Airborne	Azithromycin,Ceftriaxone	0	1	48.9	4	4	37	10	2	20.67
Ghana	2,019	4	Secondary	Emergency	K. pneumoniae	CSF	Hospital	78	Female	0	1	0	1	5	44	1	1	20	3	None	Multiple	2	46	None	Ceftriaxone	0	1	44.2	7	0	25	13	1	18.76
Cote d'Ivoire	2,024	1	Secondary	Emergency	S. aureus	CSF	Community	0	Female	0	0	0	0	1	2	0	1	0	0	Advanced	Multiple	8	63	Contact	none	0	0	0.6	0	6	42.5	5	0	0.18
Morocco	2,019	3	Tertiary	ICU	K. pneumoniae	CSF	Hospital	54	Female	1	0	0	0	1	58	1	0	19	11	Basic	Tetracycline	6	34	Contact	Vancomycin	0	1	63.4	2	2	26	5	1	22.02
Nigeria	2,019	2	Secondary	Surgical	K. pneumoniae	Urine	Community	50	Male	2	0	0	0	1	4	0	0	2	2	Moderate	Tetracycline	6	70	None	none	0	0	7.2	4	4	41	5	0	4.16
Tanzania	2,019	2	Private	Medical	K. pneumoniae	CSF	Hospital	82	Male	1	1	0	0	1	3	0	0	1	1	Advanced	Sulfonamides	8	83	Contact	none	0	0	3.9	6	6	52.5	5	0	4.17
Malawi	2,019	4	Primary	Surgical	K. pneumoniae	Stool	Hospital	33	Female	4	1	0	1	5	12	0	0	2	5	Moderate	Tetracycline	5	25	None	Imipenem,Azithromycin	0	1	15.6	15	4	17.5	13	2	16.18
Burkina Faso	2,024	3	Private	Maternity	A. baumannii	Stool	Community	1	Male	2	0	0	0	1	10	0	0	2	2	Advanced	Penicillin	10	61	Airborne	none	0	0	9	4	6	43.5	5	0	4.7
Nigeria	2,024	4	Secondary	OPD	E. coli	Urine	Community	41	Male	2	1	0	1	3	45	0	0	11	1	Basic	Penicillin	6	57	None	Gentamicin,Meropenem	0	1	26.5	11	2	34.5	9	2	17.45
Nigeria	2,022	1	Secondary	Surgical	Shigella	CSF	Community	36	Female	2	0	1	0	2	5	0	0	8	9	Basic	Penicillin	5	24	None	Imipenem,Ceftriaxone,Amoxicillin-clav	0	1	27.5	6	2	17	7	3	17.25
DRC	2,019	2	Private	Paediatric	A. baumannii	Wound	Hospital	13	Male	5	0	0	0	1	4	1	0	15	4	Basic	Penicillin	2	48	Airborne	Amoxicillin-clav,Meropenem,Ceftriaxone	1	1	29.2	10	2	29	5	3	19.76
South Africa	2,020	4	Tertiary	ICU	S. aureus	Stool	Community	17	Female	4	0	0	0	1	23	1	1	0	2	Basic	Penicillin	4	61	Airborne	Gentamicin	0	1	15.9	8	2	37.5	5	1	10.77
Egypt	2,023	1	Primary	Surgical	S. aureus	CSF	Community	57	Male	1	0	0	0	0	2	0	0	2	2	None	Penicillin	9	61	Airborne	none	0	0	6.6	2	0	42.5	3	0	2.98
Egypt	2,023	1	Tertiary	Surgical	E. coli	Urine	Hospital	70	Male	5	0	0	1	2	43	0	1	4	1	None	Penicillin	4	46	Contact	Amoxicillin-clav,Meropenem,Imipenem	0	1	18.9	13	0	30	7	3	18.17
Tanzania	2,020	2	Primary	Emergency	S. aureus	CSF	Community	44	Female	2	0	0	0	0	4	0	1	3	2	Moderate	Sulfonamides	6	69	Airborne	none	0	0	8.2	4	4	43.5	3	0	4.46
Algeria	2,020	4	Primary	Emergency	A. baumannii	CSF	Community	84	Male	1	0	0	0	0	7	0	1	2	0	Basic	None	8	61	Airborne	none	0	0	4.1	2	2	41.5	0	0	2.23
Egypt	2,021	3	Tertiary	Paediatric	K. pneumoniae	Blood	Hospital	10	Male	0	0	0	0	4	34	1	1	20	1	Moderate	Multiple	8	60	None	Amoxicillin-clav	0	1	37.2	0	4	38	11	1	13.16
Uganda	2,021	2	Primary	Surgical	P. aeruginosa	Wound	Community	3	Male	0	0	0	1	0	1	0	0	1	0	Moderate	Penicillin	10	77	Droplet	none	0	0	1.3	3	4	51.5	3	0	1.89
Tanzania	2,023	1	Primary	Emergency	P. aeruginosa	Urine	Hospital	14	Female	4	0	1	0	1	59	0	1	19	2	None	Multiple	4	46	Droplet	Azithromycin,Amoxicillin-clav,Gentamicin	0	1	40.7	10	0	30	5	3	23.21
Tanzania	2,024	1	Primary	ICU	E. coli	Urine	Community	67	Female	1	0	0	0	1	10	0	0	1	2	Advanced	Tetracycline	9	72	Droplet	none	0	0	8	2	6	48	5	0	3.4
Niger	2,021	1	Private	Medical	E. coli	Urine	Community	33	Male	2	0	0	0	2	56	0	0	21	2	Basic	None	4	33	None	Gentamicin	1	1	41.8	4	2	20.5	4	1	16.54
Algeria	2,024	1	Primary	Emergency	S. pneumoniae	Stool	Community	77	Female	2	0	0	0	0	4	0	0	2	2	Moderate	Multiple	5	91	None	none	0	0	7.2	4	4	50.5	3	0	4.16
Uganda	2,019	1	Secondary	Medical	N. gonorrhoeae	CSF	Hospital	25	Male	4	1	0	0	2	5	1	0	2	3	Basic	Penicillin	5	67	None	Ceftriaxone,Imipenem,Amoxicillin-clav	0	1	14.5	12	2	38.5	7	3	16.35
Madagascar	2,020	4	Tertiary	Medical	S. aureus	CSF	Community	80	Male	2	0	0	1	4	28	1	1	9	12	None	Penicillin	4	29	None	Gentamicin,Meropenem	1	1	46.4	7	0	18.5	11	2	21.42
Ethiopia	2,019	4	Secondary	Maternity	K. pneumoniae	Blood	Community	8	Female	2	0	0	0	4	27	1	0	14	4	Moderate	None	2	35	Droplet	Ceftriaxone	1	1	35.1	4	4	22.5	8	1	14.53
Cote d'Ivoire	2,023	3	Private	Maternity	K. pneumoniae	Stool	Community	43	Female	0	0	0	0	1	6	0	0	1	0	Moderate	Penicillin	9	93	Contact	none	0	0	2.8	0	4	58.5	5	0	0.84
Uganda	2,019	1	Secondary	Maternity	A. baumannii	Urine	Community	16	Female	1	0	0	0	0	2	1	1	1	2	Moderate	Tetracycline	6	78	Airborne	none	0	0	10.6	2	4	48	3	0	4.18
Ethiopia	2,022	1	Secondary	ICU	S. aureus	Wound	Community	78	Female	1	0	0	0	1	4	0	0	2	2	Advanced	None	6	65	None	none	0	0	7.2	2	6	38.5	2	0	3.16
South Africa	2,019	4	Private	Surgical	A. baumannii	Wound	Hospital	79	Female	1	0	0	0	0	1	0	0	0	0	Moderate	None	6	89	None	none	0	0	0.3	2	4	50.5	0	0	1.09
Cote d'Ivoire	2,020	2	Private	Emergency	E. coli	CSF	Veterinary-contact	55	Female	0	0	0	0	1	8	0	0	3	1	None	Multiple	7	92	Droplet	none	0	0	7.4	0	0	56	5	0	2.22
Senegal	2,019	3	Primary	OPD	S. pneumoniae	Stool	Community	20	Female	2	0	0	0	1	48	1	1	1	6	None	Multiple	4	32	Droplet	Ceftriaxone,Metronidazole,Ciprofloxacin	0	1	32.4	4	0	23	5	3	17.72
DRC	2,023	1	Secondary	OPD	P. aeruginosa	CSF	Veterinary-contact	12	Male	2	0	0	0	5	36	1	1	8	14	Basic	Sulfonamides	2	39	Contact	Azithromycin,Gentamicin	0	1	51.8	4	2	24.5	13	2	21.54
Egypt	2,023	3	Tertiary	Maternity	P. aeruginosa	Wound	Community	73	Male	3	0	0	0	2	41	0	0	19	8	Basic	Sulfonamides	5	24	Airborne	Ciprofloxacin,Azithromycin,Amoxicillin-clav	0	1	47.3	6	2	20	7	3	23.19
Egypt	2,021	3	Secondary	Maternity	S. aureus	Wound	Veterinary-contact	78	Male	0	0	1	0	0	1	0	0	0	1	Moderate	Tetracycline	7	88	Droplet	none	0	0	2.3	2	4	54	3	0	1.69
Senegal	2,019	1	Secondary	OPD	P. aeruginosa	Wound	Long-term-care	7	Male	0	1	0	0	1	5	0	1	0	1	Advanced	None	10	72	Contact	none	0	0	3.5	4	6	49	2	0	3.05
Egypt	2,019	4	Private	Paediatric	E. coli	Urine	Community	53	Male	2	0	0	0	0	5	0	0	0	1	Advanced	Sulfonamides	10	95	Airborne	none	0	0	3.5	4	6	60.5	3	0	3.05
Ethiopia	2,023	2	Secondary	Surgical	S. aureus	Wound	Community	56	Female	2	0	0	0	0	2	0	0	0	1	Moderate	Penicillin	8	84	Contact	none	0	0	2.6	4	4	53	3	0	2.78

End of preview. Expand in Data Studio

AMR Surveillance Dataset | Africa (Electric Sheep Africa metadata inventory)

Size category: 10K<n<100K - Formats: parquet, optimized-parquet - Sector: health - Engineered by Electric Sheep Africa

TL;DR

This dataset is part of the Electric Sheep Africa catalog on Hugging Face. It is indexed for African data discovery with standardized metadata, loading guidance, provenance notes, and analyst-oriented context.

What This Dataset Covers

Health datasets help researchers examine disease burden, service delivery, risk factors, outcomes, and public-health program performance.

Dataset context from the existing Hugging Face card: AMR Surveillance Dataset Description A synthetic tabular dataset for antimicrobial resistance surveillance in African healthcare facilities. Addresses the worst global AMR data gap where Africa bears the highest burden but has the weakest surveillance infrastructure. Dataset Statistics Property Value Total rows 10,000 Positive cases (label=1) 5,000 Control cases (label=0) 5,000 Countries represented 20 Temporal coverage 2019–2024… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/africa-amr-surveillance.

Dataset Profile

Field	Value
Hugging Face repo	`electricsheepafrica/africa-amr-surveillance`
Sector	health
Topic tags	synthetic, synthetic-data, tabular-classification, antimicrobial-resistance, amr, healthcare, one-health
Modalities	`tabular`, `text`
Formats	`parquet`, `optimized-parquet`
Size category	`10K<n<100K`
Countries	Africa-wide or source-defined African coverage
ISO3 coverage	`not declared`
Last modified on HF	`2026-05-29 13:53:29+00:00`
Inventory snapshot	`2026-07-16T16:00:34Z`

How To Read This Dataset

Start from the repository files and the dataset viewer when available.
Treat the README context as a fast orientation layer; confirm variable definitions and units in the data files before modeling.
Use explicit country columns when present. When geography is only implied by the title or source metadata, document that assumption in downstream analysis.
Preserve missing values until you have a defensible imputation rule.

Usage

from datasets import load_dataset

ds = load_dataset("electricsheepafrica/africa-amr-surveillance")
print(ds)

split_name = next(iter(ds))
table = ds[split_name]
print(table.features)
print(table[:3])

Convert To Pandas When Tabular

from datasets import Dataset

first_split = ds[next(iter(ds))]
if isinstance(first_split, Dataset):
    df = first_split.to_pandas()
    print(df.head())

Data Quality Notes

This card was standardized from the Electric Sheep Africa Hugging Face metadata inventory.
Exact schema, row counts, and source files should be inspected in the repository data files.
Metadata gaps from the inventory: country, upstream_publisher, license, language.
Do not infer policy meaning from labels alone; confirm definitions, units, and methods in the source material.

Source And Provenance

Source context: Electric Sheep Africa metadata inventory
Publisher/source attribution: Public dataset metadata
License: Source-specific or other license
Hugging Face URL: https://huggingface.co/datasets/electricsheepafrica/africa-amr-surveillance
Inventory retrieved at: 2026-07-16T16:00:34Z

Suggested Analyses

Inspect schema and missingness before modeling.
Profile variables by geography, time, and subgroup columns where present.
Join with other Electric Sheep Africa datasets using explicit country, year, and indicator fields when available.
Build reproducible notebooks that cite both the original source context and the Electric Sheep Africa Hugging Face repo.

Citation

@misc{electric_sheep_africa_africa_amr_surveillance_2026,
  title        = {AMR Surveillance Dataset | Africa (Electric Sheep Africa metadata inventory)},
  author       = {Public dataset metadata},
  year         = {2026},
  url          = {https://huggingface.co/datasets/electricsheepafrica/africa-amr-surveillance},
  publisher    = {Hugging Face Datasets, engineered by Electric Sheep Africa},
  howpublished = {\url{https://huggingface.co/datasets/electricsheepafrica/africa-amr-surveillance}}
}

License

Released under Source-specific or other license.

Original source rights remain with the original publisher or data provider. Electric Sheep Africa engineering standardizes discovery metadata, documentation, and usage guidance for analysis on Hugging Face.

About Electric Sheep Africa

Electric Sheep Africa publishes ML-ready African public datasets on Hugging Face.

Provenance: metadata-backed README standardized 2026-08-12 by the Electric Sheep Africa README system. Inventory source: catalog/esa_metadata_inventory/master_metadata.jsonl.

Downloads last month: 16

Collection including electricsheepafrica/africa-amr-surveillance

Africa · Health

Collection

Health system and disease data for Africa. Sources: WHO, DHS Program, Global Healthsites, malaria and epidemic tracking. • 84 items • Updated May 29